A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer

Gilberto Lopes, Stefan Glück, Kiran Avancha, Alberto J. Montero

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences